Cargando…

Psoriasis: Comorbidities

Psoriasis has long been known as a disease with many complications, but was attributed to diet and obesity. However, in recent years, psoriasis itself has been recognized as a series of systemic inflammatory diseases, and that the cytokines involved can induce a variety of other diseases. Individual...

Descripción completa

Detalles Bibliográficos
Autor principal: Yamazaki, Fumikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252780/
https://www.ncbi.nlm.nih.gov/pubmed/33763899
http://dx.doi.org/10.1111/1346-8138.15840
_version_ 1783717373495214080
author Yamazaki, Fumikazu
author_facet Yamazaki, Fumikazu
author_sort Yamazaki, Fumikazu
collection PubMed
description Psoriasis has long been known as a disease with many complications, but was attributed to diet and obesity. However, in recent years, psoriasis itself has been recognized as a series of systemic inflammatory diseases, and that the cytokines involved can induce a variety of other diseases. Individuals with psoriasis were also found to have higher incidences of cerebral and cardiovascular diseases and a younger age at death compared to healthy individuals. However, no clear guidelines have been defined regarding how much vascular lesion testing should be performed in patients with psoriasis. In this report, I attempt to unravel the objective data on psoriasis and its complications from various reviews and reports, and introduce the impact of biologics, which are currently the main treatment for psoriasis, on cardiac vascular disease.
format Online
Article
Text
id pubmed-8252780
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82527802021-07-12 Psoriasis: Comorbidities Yamazaki, Fumikazu J Dermatol Review Articles Psoriasis has long been known as a disease with many complications, but was attributed to diet and obesity. However, in recent years, psoriasis itself has been recognized as a series of systemic inflammatory diseases, and that the cytokines involved can induce a variety of other diseases. Individuals with psoriasis were also found to have higher incidences of cerebral and cardiovascular diseases and a younger age at death compared to healthy individuals. However, no clear guidelines have been defined regarding how much vascular lesion testing should be performed in patients with psoriasis. In this report, I attempt to unravel the objective data on psoriasis and its complications from various reviews and reports, and introduce the impact of biologics, which are currently the main treatment for psoriasis, on cardiac vascular disease. John Wiley and Sons Inc. 2021-03-25 2021-06 /pmc/articles/PMC8252780/ /pubmed/33763899 http://dx.doi.org/10.1111/1346-8138.15840 Text en © 2021 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Review Articles
Yamazaki, Fumikazu
Psoriasis: Comorbidities
title Psoriasis: Comorbidities
title_full Psoriasis: Comorbidities
title_fullStr Psoriasis: Comorbidities
title_full_unstemmed Psoriasis: Comorbidities
title_short Psoriasis: Comorbidities
title_sort psoriasis: comorbidities
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252780/
https://www.ncbi.nlm.nih.gov/pubmed/33763899
http://dx.doi.org/10.1111/1346-8138.15840
work_keys_str_mv AT yamazakifumikazu psoriasiscomorbidities